FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Nichols

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Co-author Network

Publications

TOP 3
Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas H Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Irene Bosch; Sharone Green; Philip Bedford
A live, attenuated recombinant West Nile virus vaccine.
Farshad Guirakhoo; Scott Kitchener; Dennis Morrison; Remi Forrat; Karen McCarthy; Richard Nichols; Sutee Yoksan; Xiaochu Duan; Thomas H Ermak; Niranjan Kanesa-Thasan; Philip Bedford; Jean Lang; Marie-Jose Quentin-Millet; Thomas P Monath
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Thomas P Monath; Martin S Cetron; Karen McCarthy; Richard Nichols; W Tad Archambault; Leisa Weld; Philip Bedford
Yellow fever 17D vaccine safety and immunogenicity in the elderly.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Nichols (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas H Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Irene Bosch; Sharone Green; Philip Bedford
A live, attenuated recombinant West Nile virus vaccine.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6694-9.
2006: Farshad Guirakhoo; Scott Kitchener; Dennis Morrison; Remi Forrat; Karen McCarthy; Richard Nichols; Sutee Yoksan; Xiaochu Duan; Thomas H Ermak; Niranjan Kanesa-Thasan; Philip Bedford; Jean Lang; Marie-Jose Quentin-Millet; Thomas P Monath
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Human vaccines 2006;2(2):60-7.
2005: Thomas P Monath; Martin S Cetron; Karen McCarthy; Richard Nichols; W Tad Archambault; Leisa Weld; Philip Bedford
Yellow fever 17D vaccine safety and immunogenicity in the elderly.
Human vaccines 2005;1(5):207-14.
2005: Andrew W Artenstein; Casey Johnson; Thomas C Marbury; Dennis Morrison; Paul S Blum; Tracy Kemp; Richard Nichols; John P Balser; Michelle Currie; Thomas P Monath
A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.
Vaccine 2005;23(25):3301-9.
2005: Vivian E Belmusto-Worn; Jose L Sanchez; Karen McCarthy; Richard Nichols; Christian T Bautista; Alan J Magill; Giovanna Pastor-Cauna; Carlos Echevarria; Victor A Laguna-Torres; Billey K Samame; Maria E Baldeon; James P Burans; James G Olson; Philip Bedford; Scott Kitchener; Thomas P Monath
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
The American journal of tropical medicine and hygiene 2005;72(2):189-97.
2005: Casey Johnson; Thomas P Monath; Niranjan Kanesa-Thasan; Danell Mathis; Chuck Miller; Seth Shapiro; Richard Nichols; Karen McCarthy; Alison Deary; Philip Bedford
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trial.
Human vaccines 2005;1(1):24-9.
2004: Thomas P Monath; Joseph R Caldwell; Wolfgang Mundt; Joan Fusco; Casey S Johnson; Mark Buller; Jian Liu; Bridget Gardner; Greg Downing; Paul S Blum; Tracy Kemp; Richard Nichols; Richard Weltzin
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2004;8 Suppl 2():S31-44.
2004: Farshad Guirakhoo; Zhenxi Zhang; G Myers; Barbara W Johnson; Konstantin V Pugachev; Richard Nichols; Nathan Brown; Inessa Levenbook; Ken Draper; S Cyrek; Jean Lang; C Fournier; B Barrere; Simon Delagrave; Thomas P Monath
A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
Journal of virology 2004;78(18):9998-10008.
2004: Farshad Guirakhoo; Konstantin V Pugachev; Zhenxi Zhang; G Myers; Inessa Levenbook; Ken Draper; Jean Lang; Simeon W Ocran; Fred Mitchell; Megan Parsons; Nathan Brown; Samantha Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; Richard Nichols; Dennis W Trent; Thomas P Monath
Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.
Journal of virology 2004;78(9):4761-75.
2003: Thomas P Monath; Farshad Guirakhoo; Richard Nichols; Sutee Yoksan; Robert Schrader; Chris Murphy; Paul Blum; Stephen Woodward; Karen McCarthy; Danell Mathis; Casey Johnson; Philip Bedford
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
The Journal of infectious diseases 2003;188(8):1213-30.
2003: Richard Weltzin; Jian Liu; Konstantin V Pugachev; Gwendolyn A Myers; Brie Coughlin; Paul S Blum; Richard Nichols; Casey Johnson; John Cruz; Jeffrey S Kennedy; Irene Bosch; Thomas P Monath
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.
Nature medicine 2003;9(9):1125-30.
2002: Thomas P Monath; Richard Nichols; W Tad Archambault; Linda Moore; Ron Marchesani; Jason Tian; Robert E Shope; Nicola Thomas; Robert Schrader; Dean Furby; Philip Bedford
Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.
The American journal of tropical medicine and hygiene 2002;66(5):533-41.
2002: Thomas P Monath; Karen McCarthy; Philip Bedford; Casey T Johnson; Richard Nichols; Sutee Yoksan; Ron Marchesani; Michael Knauber; Keith H Wells; Juan Arroyo; Farshad Guirakhoo
Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.
Vaccine 2002;20(7-8):1004-18.
2000: Thomas P Monath; Inessa Levenbook; K Soike; Zhen-Xi Zhang; Marion S Ratterree; Ken Draper; Alan D T Barrett; Richard Nichols; Richard Weltzin; Juan Arroyo; Farshad Guirakhoo
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
Journal of virology 2000;74(4):1742-51.
1998: Thomas H Ermak; Paul J Giannasca; Richard Nichols; Gwendolyn A Myers; J Nedrud; Richard Weltzin; Cynthia K Lee; Harry Kleanthous; Thomas P Monath
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
The Journal of experimental medicine 1998;188(12):2277-88.
1998: Harry Kleanthous; Gwendolyn A Myers; KM Georgakopoulos; Timothy John Tibbitts; JW Ingrassia; H L Gray; R Ding; Z Z Zhang; W Lei; Richard Nichols; Cynthia K Lee; Thomas H Ermak; Thomas P Monath
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
Infection and immunity 1998;66(6):2879-86.